News
UnitedHealth (UNH) stock, Humana (HUM) stock, CVS Health (CVS) stock rally as Medicare finalizes a favorable rate decision.
The decision to raise Medicare Advantage plan payments by over $25 billion has led to a positive response in the stock market.
Today, Zacks Equity Research discusses UnitedHealth Group Inc. UNH, Humana Inc. HUM and Centene Corp. CNC. Industry: HMO.
5dOpinion
Zacks Investment Research on MSN3 HMO Stocks to Watch Amid Nurse Shortages, High Tech CostsThe U.S. health insurance industry, referred to as Health Maintenance Organization (HMO), is aided by membership growth on ...
With large opportunities in its target markets, management aims to continue growing at a fast pace with a long-term annual earnings per share growth goal of 11%-15%. While Humana appears focused ...
AM Best, a global credit rating agency, maintained its Long-Term Issue Credit Rating of "bbb" (Good) for Humana Inc .’s $1.25 billion 5.375% senior unsecured notes due in 2031. The rating affirmation ...
AM Best has commented that the Long-Term Issue Credit Rating of "bbb" (Good) on the $1.25 billion 5.375% senior unsecured ...
HUM benefits from a cost-effective health plan suite, continued expansion endeavors and a strong 2025 business outlook.
Harbour Investments Inc.’s holdings in Humana were worth $80,000 as of its most recent SEC filing. A number of other hedge funds also recently bought and sold shares of HUM.
If these positive market conditions materialize, FactSet’s recent investments in technology and product development could pay off, allowing the company to meet or exceed its financial targets and ...
Her expertise is in personal finance and investing, and real estate. Learn about our editorial policies Net present value (NPV) assesses the profitability of an investment on the basis that a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results